ZyVersa Therapeutics, Inc. (ZVSA)
USD 0.6
(-3.3%)
USD 0.6
(-3.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1089.67 USD | 65.54% |
| 2022 | -930.25 USD | -15192.32% |
| 2021 | -173.66 USD | 32.52% |
| 2020 | -272.45 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -3.31 USD | 26.97% |
| 2024 Q1 | -4.53 USD | 86.23% |
| 2023 Q3 | -3.28 USD | 97.87% |
| 2023 Q1 | -13.59 USD | 26.34% |
| 2023 FY | - USD | 65.54% |
| 2023 Q2 | -153.90 USD | -1032.45% |
| 2023 Q4 | -3.29 USD | -0.3% |
| 2022 Q1 | -0.18 USD | 10.0% |
| 2022 FY | - USD | -15192.32% |
| 2022 Q2 | -0.18 USD | 0.0% |
| 2022 Q4 | -18.45 USD | -4400.0% |
| 2022 Q3 | -0.41 USD | -127.78% |
| 2021 Q1 | -4.60 USD | 0.0% |
| 2021 FY | - USD | 32.52% |
| 2021 Q4 | -0.20 USD | -115.29% |
| 2021 Q3 | -0.09 USD | 99.79% |
| 2021 Q2 | -45.00 USD | -878.26% |
| 2020 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AbCellera Biologics Inc. | -0.51 USD | -213560.784% |
| Alkermes plc | 2.14 USD | 51019.159% |
| Agenus Inc. | -13.75 USD | -7824.873% |
| Aptorum Group Limited | -0.62 USD | -175653.226% |
| Ardelyx, Inc. | -0.30 USD | -363123.333% |
| Dyadic International, Inc. | -0.24 USD | -453929.167% |
| Eton Pharmaceuticals, Inc. | -0.04 USD | -2985297.26% |
| Lantern Pharma Inc. | -1.47 USD | -74027.211% |
| Inhibikase Therapeutics, Inc. | -3.57 USD | -30422.969% |
| Novavax, Inc. | -5.41 USD | -20041.774% |
| Janux Therapeutics, Inc. | -1.32 USD | -82450.758% |
| Pyxis Oncology, Inc. | -1.85 USD | -58801.081% |
| TransCode Therapeutics, Inc. | -103.61 USD | -951.704% |
| Ocuphire Pharma, Inc. | -0.46 USD | -236784.783% |
| Outlook Therapeutics, Inc. | -4.72 USD | -22986.229% |
| Madrigal Pharmaceuticals, Inc. | -19.99 USD | -5351.076% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -87073.6% |
| SELLAS Life Sciences Group, Inc. | -1.34 USD | -81218.657% |
| Syros Pharmaceuticals, Inc. | -5.81 USD | -18655.077% |
| Barinthus Biotherapeutics plc | -1.91 USD | -56950.785% |
| Windtree Therapeutics, Inc. | -92.23 USD | -1081.47% |
| Xeris Biopharma Holdings, Inc. | -0.45 USD | -242048.889% |
| Clearside Biomedical, Inc. | -0.53 USD | -205498.113% |
| C4 Therapeutics, Inc. | -2.67 USD | -40711.61% |
| Alnylam Pharmaceuticals, Inc. | -3.52 USD | -30856.534% |
| AlloVir, Inc. | -1.83 USD | -59444.809% |
| Arrowhead Pharmaceuticals, Inc. | -1.91 USD | -56950.785% |
| VYNE Therapeutics Inc. | -2.77 USD | -39238.267% |
| Bicycle Therapeutics plc | -5.08 USD | -21350.197% |
| BioXcel Therapeutics, Inc. | -6.15 USD | -17618.211% |
| ChromaDex Corporation | -0.07 USD | -1653420.486% |
| Chimerix, Inc. | -0.93 USD | -117068.817% |
| Corbus Pharmaceuticals Holdings, Inc. | -10.31 USD | -10469.059% |
| Caribou Biosciences, Inc. | -1.38 USD | -78861.594% |
| CRISPR Therapeutics AG | -1.94 USD | -56068.557% |
| Precision BioSciences, Inc. | -15.96 USD | -6727.506% |
| Fate Therapeutics, Inc. | -1.64 USD | -66343.293% |
| Fortress Biotech, Inc. | -8.47 USD | -12765.053% |
| Fortress Biotech, Inc. | -8.47 USD | -12765.053% |
| HOOKIPA Pharma Inc. | -8.63 USD | -12526.535% |
| ImmuCell Corporation | -0.75 USD | -145189.333% |
| IDEAYA Biosciences, Inc. | -1.96 USD | -55495.408% |
| Immix Biopharma, Inc. | -0.89 USD | -122334.831% |
| Incyte Corporation | 2.67 USD | 40911.61% |
| Innoviva, Inc. | 2.92 USD | 37417.466% |
| IO Biotech, Inc. | -1.98 USD | -54933.838% |
| Jaguar Health, Inc. | -107.42 USD | -914.401% |
| Keros Therapeutics, Inc. | -5.20 USD | -20855.192% |
| Ligand Pharmaceuticals Incorporated | 3.02 USD | 36181.788% |
| ContextLogic Inc. | -13.36 USD | -8056.213% |
| MiMedx Group, Inc. | 0.48 USD | 227114.583% |
| MEI Pharma, Inc. | 2.67 USD | 40911.61% |
| NextCure, Inc. | -2.25 USD | -48329.778% |
| Onconetix, Inc. | -2.19 USD | -49656.621% |
| Oncternal Therapeutics, Inc. | -13.43 USD | -8013.701% |
| Opthea Limited | -0.35 USD | -311234.286% |
| Psyence Biomedical Ltd. | -7.85 USD | -13781.146% |
| Vaxcyte, Inc. | -4.14 USD | -26220.531% |
| PDS Biotechnology Corporation | -1.39 USD | -78293.525% |
| Precigen, Inc. | -0.39 USD | -279302.564% |
| Pharming Group N.V. | -0.16 USD | -680943.75% |
| Phathom Pharmaceuticals, Inc. | -3.93 USD | -27626.972% |
| Pieris Pharmaceuticals, Inc. | -21.80 USD | -4898.486% |
| PureTech Health plc | -2.38 USD | -45684.454% |
| Rigel Pharmaceuticals, Inc. | -1.44 USD | -75571.528% |
| Avidity Biosciences, Inc. | -2.91 USD | -37345.704% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -87073.6% |
| Sangamo Therapeutics, Inc. | -1.48 USD | -73526.351% |
| Sol-Gel Technologies Ltd. | -1.01 USD | -107788.119% |
| Acelyrin, Inc. | -5.43 USD | -19967.587% |
| Salarius Pharmaceuticals, Inc. | -0.00 USD | -28675426.316% |
| Summit Therapeutics Inc. | -0.99 USD | -109967.677% |
| Sensei Biotherapeutics, Inc. | -1.22 USD | -89217.213% |
| Senti Biosciences, Inc. | -16.01 USD | -6706.184% |
| Stoke Therapeutics, Inc. | -2.38 USD | -45684.454% |
| Elevation Oncology, Inc. | -1.34 USD | -81218.657% |
| Alaunos Therapeutics, Inc. | -21.97 USD | -4859.809% |
| Telomir Pharmaceuticals, Inc. Common Stock | -0.44 USD | -247552.273% |
| Entrada Therapeutics, Inc. | -0.20 USD | -544735.0% |
| VistaGen Therapeutics, Inc. | -1.52 USD | -71588.816% |
| Kintara Therapeutics, Inc. | -3.23 USD | -33635.913% |
| Wave Life Sciences Ltd. | -0.54 USD | -201690.741% |
| Seer, Inc. | -1.35 USD | -80616.296% |
| Verrica Pharmaceuticals Inc. | -1.48 USD | -73526.351% |
| Aadi Bioscience, Inc. | -2.44 USD | -44558.607% |
| ESSA Pharma Inc. | -0.60 USD | -181511.667% |
| GlycoMimetics, Inc. | -0.58 USD | -187774.138% |
| GT Biopharma, Inc. | -5.64 USD | -19220.39% |
| Inhibrx Biosciences, Inc. | -5.12 USD | -21182.617% |
| Akebia Therapeutics, Inc. | -0.28 USD | -389067.857% |
| Catalyst Pharmaceuticals, Inc. | 0.67 USD | 162737.313% |
| Longboard Pharmaceuticals, Inc. | -2.39 USD | -45492.887% |
| Orchestra BioMed Holdings, Inc. | -1.48 USD | -73526.351% |
| Alzamend Neuro, Inc. | -14.72 USD | -7302.649% |
| Sorrento Therapeutics, Inc. | -1.37 USD | -79437.956% |
| TRACON Pharmaceuticals, Inc. | -2.20 USD | -49430.455% |
| Viracta Therapeutics, Inc. | -1.32 USD | -82450.758% |
| Rocket Pharmaceuticals, Inc. | -2.92 USD | -37217.466% |
| Aptose Biosciences Inc. | -7.58 USD | -14275.594% |
| Soligenix, Inc. | -12.66 USD | -8507.188% |
| Century Therapeutics, Inc. | -2.30 USD | -47276.957% |
| Kura Oncology, Inc. | -2.08 USD | -52287.981% |
| TScan Therapeutics, Inc. | -1.36 USD | -80022.794% |
| Intensity Therapeutics, Inc. | -1.38 USD | -78861.594% |
| Ocean Biomedical, Inc. | -0.03 USD | -4143131.939% |
| CytomX Therapeutics, Inc. | -0.01 USD | -14151458.442% |
| Autolus Therapeutics plc | -1.20 USD | -90705.833% |
| Mineralys Therapeutics, Inc. | -1.99 USD | -54657.286% |
| EyePoint Pharmaceuticals, Inc. | -1.82 USD | -59771.978% |
| Eterna Therapeutics Inc. | -4.08 USD | -26607.598% |
| Adaptive Biotechnologies Corporation | -1.56 USD | -69750.641% |
| GRI Bio, Inc. | -28.25 USD | -3757.239% |
| Xenetic Biosciences, Inc. | -2.71 USD | -40109.225% |
| Tenaya Therapeutics, Inc. | -1.68 USD | -64761.31% |
| IGM Biosciences, Inc. | -4.71 USD | -23035.244% |
| INmune Bio, Inc. | -1.67 USD | -65149.701% |
| Heron Therapeutics, Inc. | -0.80 USD | -136108.75% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -14162.696% |
| Pasithea Therapeutics Corp. | -12.65 USD | -8513.992% |
| Entero Therapeutics, Inc. | -47.88 USD | -2175.835% |
| Milestone Pharmaceuticals Inc. | -1.39 USD | -78293.525% |
| X4 Pharmaceuticals, Inc. | -0.57 USD | -191070.175% |
| Atara Biotherapeutics, Inc. | -65.18 USD | -1571.786% |
| Coherus BioSciences, Inc. | -2.53 USD | -42969.96% |
| Verastem, Inc. | -3.96 USD | -27416.919% |
| Abeona Therapeutics Inc. | -2.53 USD | -42969.96% |
| Pliant Therapeutics, Inc. | -2.75 USD | -39524.364% |
| Tonix Pharmaceuticals Holding Corp. | -219.09 USD | -397.362% |
| Histogen Inc. | -3.46 USD | -31393.353% |
| Aprea Therapeutics, Inc. | -3.95 USD | -27486.582% |
| Surrozen, Inc. | -21.33 USD | -5008.626% |
| Organovo Holdings, Inc. | -1.60 USD | -68004.375% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -40865.038% |
| Ovid Therapeutics Inc. | -0.74 USD | -147152.703% |
| Panbela Therapeutics, Inc. | -232.42 Thousand USD | 99.531% |
| CASI Pharmaceuticals, Inc. | -2.02 USD | -53844.059% |
| Cadrenal Therapeutics, Inc. Common Stock | -0.62 USD | -175653.226% |
| Centessa Pharmaceuticals plc | -1.57 USD | -69305.732% |
| Hepion Pharmaceuticals, Inc. | -12.32 USD | -8744.724% |
| Arcturus Therapeutics Holdings Inc. | -1.12 USD | -97191.964% |
| BioRestorative Therapies, Inc. | -2.47 USD | -44016.194% |
| Apollomics, Inc. | -2.32 USD | -46868.534% |
| Amarin Corporation plc | -0.15 USD | -726346.667% |
| Mesoblast Limited | -0.89 USD | -122334.831% |
| Turnstone Biologics Corp. | -4.77 USD | -22744.235% |
| Kymera Therapeutics, Inc. | -2.52 USD | -43140.873% |
| Synaptogenix, Inc. | -29.56 USD | -3586.299% |
| Tiziana Life Sciences Ltd | -0.16 USD | -680943.75% |
| Aurinia Pharmaceuticals Inc. | -0.54 USD | -201690.741% |
| BriaCell Therapeutics Corp. | -0.29 USD | -375648.276% |
| Monopar Therapeutics Inc. | -0.58 USD | -187774.138% |
| Exelixis, Inc. | 0.65 USD | 167741.538% |
| Better Therapeutics, Inc. | -1.69 USD | -64377.515% |
| Nurix Therapeutics, Inc. | -2.65 USD | -41019.623% |
| Apellis Pharmaceuticals, Inc. | -4.45 USD | -24386.966% |
| NLS Pharmaceutics AG | -0.32 USD | -340421.875% |
| Dermata Therapeutics, Inc. | -40.18 USD | -2611.971% |
| Aridis Pharmaceuticals, Inc. | -1.64 USD | -66343.293% |
| Gritstone bio, Inc. | -1.20 USD | -90705.833% |
| Jasper Therapeutics, Inc. | -6.18 USD | -17532.201% |
| TNF Pharmaceuticals, Inc. | -5.33 USD | -20344.09% |
| Avid Bioservices, Inc. | -2.23 USD | -48764.126% |
| Insmed Incorporated | -5.34 USD | -20305.805% |
| Virpax Pharmaceuticals, Inc. | -12.97 USD | -8301.465% |
| MediWound Ltd. | -0.75 USD | -145189.333% |
| OmniAb, Inc. | -0.51 USD | -213560.784% |
| Alector, Inc. | -1.56 USD | -69750.641% |
| Seres Therapeutics, Inc. | -0.89 USD | -122334.831% |
| Checkpoint Therapeutics, Inc. | -2.77 USD | -39238.267% |
| Zai Lab Limited | -3.46 USD | -31393.353% |
| Revance Therapeutics, Inc. | -3.83 USD | -28350.914% |
| Aura Biosciences, Inc. | -1.93 USD | -56359.585% |
| Lyell Immunopharma, Inc. | -0.93 USD | -117068.817% |
| Immunic, Inc. | -2.11 USD | -51543.128% |
| Tarsus Pharmaceuticals, Inc. | -4.62 USD | -23485.931% |
| Veracyte, Inc. | -1.02 USD | -106730.392% |
| InMed Pharmaceuticals Inc. | -1.01 USD | -107788.119% |
| FibroGen, Inc. | -2.92 USD | -37217.466% |
| SeaStar Medical Holding Corporation | -30.29 USD | -3497.458% |
| Adial Pharmaceuticals, Inc. | -5.44 USD | -19930.699% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.14 USD | -5907.001% |
| Jazz Pharmaceuticals plc | 6.95 USD | 15778.705% |
| Cyclacel Pharmaceuticals, Inc. | -26.75 USD | -3973.533% |
| Amylyx Pharmaceuticals, Inc. | 0.73 USD | 149369.863% |
| TG Therapeutics, Inc. | 0.09 USD | 1220335.162% |
| Galecto, Inc. | -36.08 USD | -2920.15% |
| Calithera Biosciences, Inc. | -7.94 USD | -13623.804% |
| Fortrea Holdings Inc. | -0.04 USD | -2844991.384% |
| KalVista Pharmaceuticals, Inc. | -3.44 USD | -31576.453% |
| Aptevo Therapeutics Inc. | -62.62 USD | -1640.131% |
| XBiotech Inc. | -0.81 USD | -134427.16% |
| Jasper Therapeutics, Inc. | -6.18 USD | -17532.201% |
| Lyra Therapeutics, Inc. | -1.26 USD | -86381.746% |
| Foghorn Therapeutics Inc. | -2.34 USD | -46467.094% |
| Y-mAbs Therapeutics, Inc. | -0.49 USD | -222281.633% |
| Theravance Biopharma, Inc. | -1.00 USD | -108867.0% |
| Ultragenyx Pharmaceutical Inc. | -8.25 USD | -13108.121% |
| Metagenomi, Inc. Common Stock | -1.82 USD | -59771.978% |
| Vaxxinity, Inc. | -0.45 USD | -242048.889% |
| BioCryst Pharmaceuticals, Inc. | -1.18 USD | -92244.915% |
| Gain Therapeutics, Inc. | -1.71 USD | -63623.392% |
| Cartesian Therapeutics, Inc. | -42.49 USD | -2464.533% |
| NexImmune, Inc. | -30.82 USD | -3435.594% |
| Creative Medical Technology Holdings, Inc. | -3.76 USD | -28880.585% |
| Marker Therapeutics, Inc. | -1.93 USD | -56359.585% |
| Regeneron Pharmaceuticals, Inc. | 37.05 USD | 3041.08% |
| Chemomab Therapeutics Ltd. | -2.06 USD | -52796.602% |
| Scopus BioPharma Inc. | -0.55 USD | -198021.818% |
| RAPT Therapeutics, Inc. | -3.05 USD | -35626.885% |
| Ainos, Inc. | -3.36 USD | -32330.655% |
| Pluri Inc. | -3.99 USD | -27210.025% |
| Prothena Corporation plc | -2.76 USD | -39380.797% |
| Adaptimmune Therapeutics plc | -0.57 USD | -191070.175% |
| Celularity Inc. | -11.02 USD | -9788.113% |
| Rallybio Corporation | -1.84 USD | -59121.196% |
| Cue Biopharma, Inc. | -1.11 USD | -98068.468% |
| MeiraGTx Holdings plc | -1.49 USD | -73032.215% |
| Omeros Corporation | -1.88 USD | -57861.17% |
| Humacyte, Inc. | -1.07 USD | -101738.318% |
| Immunocore Holdings plc | -1.13 USD | -96330.973% |
| Cocrystal Pharma, Inc. | -1.86 USD | -58484.409% |
| Cidara Therapeutics, Inc. | -5.25 USD | -20655.619% |
| Blueprint Medicines Corporation | -8.37 USD | -12918.757% |
| CalciMedica, Inc. | -7.65 USD | -14144.052% |
| Cabaletta Bio, Inc. | -1.65 USD | -65940.606% |
| Marinus Pharmaceuticals, Inc. | -2.63 USD | -41332.319% |
| Scholar Rock Holding Corporation | -1.99 USD | -54657.286% |
| Sana Biotechnology, Inc. | -1.46 USD | -74534.932% |
| Pulmatrix, Inc. | -3.87 USD | -28056.848% |
| Elicio Therapeutics, Inc. | -6.96 USD | -15556.178% |
| Vigil Neuroscience, Inc. | -2.13 USD | -51058.216% |
| Intellia Therapeutics, Inc. | -5.42 USD | -20004.613% |
| Adlai Nortye Ltd. American Depositary Shares | -7.26 USD | -14909.229% |
| Cytokinetics, Incorporated | -5.45 USD | -19893.945% |
| Eloxx Pharmaceuticals, Inc. | -16.65 USD | -6444.565% |
| Nutriband Inc. | -0.69 USD | -157823.188% |
| Protara Therapeutics, Inc. | -3.57 USD | -30422.969% |
| Vor Biopharma Inc. | -1.75 USD | -62166.857% |
| Roivant Sciences Ltd. | 5.55 USD | 19733.694% |
| Evogene Ltd. | -5.23 USD | -20734.99% |
| ProKidney Corp. | -0.57 USD | -191070.175% |
| Applied Therapeutics, Inc. | -1.42 USD | -76637.324% |
| Hoth Therapeutics, Inc. | -2.30 USD | -47276.957% |
| BridgeBio Pharma, Inc. | -3.95 USD | -27486.582% |
| CorMedix Inc. | -0.91 USD | -119643.956% |
| BioLineRx Ltd. | -0.94 USD | -115822.34% |
| Tango Therapeutics, Inc. | -1.08 USD | -100795.37% |
| Galectin Therapeutics Inc. | -0.74 USD | -147152.703% |
| Atai Life Sciences N.V. | -0.25 USD | -435768.0% |
| Renovaro Biosciences Inc. | -0.84 USD | -129622.619% |
| Aerovate Therapeutics, Inc. | -2.87 USD | -37867.596% |
| Zentalis Pharmaceuticals, Inc. | -4.47 USD | -24277.405% |
| Sagimet Biosciences Inc. | -2.66 USD | -40865.038% |
| MediciNova, Inc. | -0.17 USD | -640882.353% |
| Praxis Precision Medicines, Inc. | -18.69 USD | -5730.23% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -165001.515% |
| GeoVax Labs, Inc. | -10.22 USD | -10562.133% |
| Axsome Therapeutics, Inc. | -5.27 USD | -20576.85% |
| Biomea Fusion, Inc. | -3.44 USD | -31576.453% |
| PTC Therapeutics, Inc. | -8.37 USD | -12918.757% |
| Mereo BioPharma Group plc | -0.04 USD | -2437640.492% |
| Cullinan Oncology, Inc. | -3.69 USD | -29430.352% |
| Syndax Pharmaceuticals, Inc. | -2.98 USD | -36466.107% |
| Absci Corporation | -1.20 USD | -90705.833% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -27278.643% |
| 4D Molecular Therapeutics, Inc. | -2.58 USD | -42135.271% |
| Dyne Therapeutics, Inc. | -3.95 USD | -27486.582% |
| Kiniksa Pharmaceuticals, Ltd. | 0.20 USD | 544935.0% |
| Ventyx Biosciences, Inc. | -3.30 USD | -32920.303% |
| Allakos Inc. | -2.14 USD | -50819.159% |
| Imunon, Inc. | -2.16 USD | -50347.685% |
| Fulcrum Therapeutics, Inc. | -1.59 USD | -68432.704% |
| Corcept Therapeutics Incorporated | 1.02 USD | 106930.392% |
| BioAtla, Inc. | -2.58 USD | -42135.271% |
| NLS Pharmaceutics AG | -0.32 USD | -340421.875% |
| Bio-Path Holdings, Inc. | -33.64 USD | -3139.209% |
| Allogene Therapeutics, Inc. | -2.09 USD | -52037.321% |
| Larimar Therapeutics, Inc. | -0.84 USD | -129622.619% |
| XOMA Corporation | -4.04 USD | -26872.03% |
| Kezar Life Sciences, Inc. | -1.40 USD | -77733.571% |
| Cara Therapeutics, Inc. | -2.19 USD | -49656.621% |
| aTyr Pharma, Inc. | -0.94 USD | -115822.34% |
| Aligos Therapeutics, Inc. | -3.52 USD | -30856.534% |
| Akero Therapeutics, Inc. | -2.89 USD | -37604.844% |
| Viridian Therapeutics, Inc. | -5.31 USD | -20421.092% |
| Eliem Therapeutics, Inc. | -1.30 USD | -83720.769% |
| EyeGate Pharmaceuticals, Inc. | -2.54 USD | -42800.394% |
| Akari Therapeutics, Plc | -2.04 USD | -53315.196% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -272417400.0% |
| Halozyme Therapeutics, Inc. | 2.13 USD | 51258.216% |
| Lexaria Bioscience Corp. | -1.01 USD | -107788.119% |
| UroGen Pharma Ltd. | -3.55 USD | -30594.93% |
| Sutro Biopharma, Inc. | -1.78 USD | -61117.416% |
| ZIVO Bioscience, Inc. | -4.60 USD | -23588.478% |
| Orgenesis Inc. | -1.91 USD | -56950.785% |
| Entera Bio Ltd. | -0.31 USD | -351406.452% |
| GH Research PLC | -0.68 USD | -160145.588% |
| Lisata Therapeutics, Inc. | -2.58 USD | -42135.271% |
| Reneo Pharmaceuticals, Inc. | -25.23 USD | -4218.946% |
| Xencor, Inc. | -2.08 USD | -52287.981% |
| 60 Degrees Pharmaceuticals, Inc. | -0.95 USD | -114602.105% |
| Replimune Group, Inc. | -3.24 USD | -33531.79% |
| Coeptis Therapeutics Holdings, Inc. | -0.83 USD | -131185.542% |
| Vanda Pharmaceuticals Inc. | 0.04 USD | 2493624.027% |
| Lexaria Bioscience Corp. | -1.01 USD | -107788.119% |
| Portage Biotech Inc. | -3.70 USD | -29350.541% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -165001.515% |
| Olema Pharmaceuticals, Inc. | -2.14 USD | -50819.159% |
| OncoCyte Corporation | -3.75 USD | -28957.867% |
| Qualigen Therapeutics, Inc. | -2.46 USD | -44195.528% |
| Processa Pharmaceuticals, Inc. | -8.48 USD | -12749.882% |
| Purple Biotech Ltd. | -0.09 USD | -1213340.98% |
| CollPlant Biotechnologies Ltd. | -0.62 USD | -175653.226% |
| scPharmaceuticals Inc. | -1.42 USD | -76637.324% |
| ProMIS Neurosciences, Inc. | -1.42 USD | -76637.324% |
| HilleVax, Inc. | -3.04 USD | -35744.408% |
| NeuroSense Therapeutics Ltd. | -0.83 USD | -131185.542% |
| Tharimmune, Inc. | -107.08 USD | -917.622% |
| Genprex, Inc. | -22.58 USD | -4725.819% |
| Neumora Therapeutics, Inc. Common Stock | -1.49 USD | -73032.215% |
| Atossa Therapeutics, Inc. | -0.24 USD | -453929.167% |
| XTL Biopharmaceuticals Ltd. | -0.00 USD | -33020203.03% |
| Virios Therapeutics, Inc. | -0.28 USD | -389067.857% |
| OKYO Pharma Limited | -0.00 USD | -181611566.667% |
| Savara Inc. | -0.33 USD | -330103.03% |
| Curis, Inc. | -8.96 USD | -12061.496% |
| Daré Bioscience, Inc. | -4.15 USD | -26157.108% |
| Carmell Therapeutics Corporation | -1.46 USD | -74534.932% |
| Titan Pharmaceuticals, Inc. | -7.41 USD | -14605.398% |
| Achieve Life Sciences, Inc. | -1.50 USD | -72544.667% |
| BeiGene, Ltd. | -8.45 USD | -12795.503% |
| Kiromic BioPharma, Inc. | -21.41 USD | -4989.538% |
| Revolution Medicines, Inc. Warrant | -3.86 USD | -28129.793% |
| Protagonist Therapeutics, Inc. | -1.39 USD | -78293.525% |
| Erasca, Inc. | -0.83 USD | -131185.542% |
| bluebird bio, Inc. | -1.93 USD | -56359.585% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -94653.913% |
| BioMarin Pharmaceutical Inc. | 0.89 USD | 122534.831% |
| DBV Technologies S.A. | -0.76 USD | -143277.632% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -94653.913% |
| Moderna, Inc. | -12.34 USD | -8730.389% |
| Vincerx Pharma, Inc. | -1.89 USD | -57554.497% |
| Fresh Tracks Therapeutics, Inc. | -0.96 USD | -113407.292% |
| Molecular Templates, Inc. | -1.80 USD | -60437.222% |
| Acrivon Therapeutics, Inc. Common Stock | -2.74 USD | -39668.978% |
| Travere Therapeutics, Inc. | -1.50 USD | -72544.667% |
| Monte Rosa Therapeutics, Inc. | -2.63 USD | -41332.319% |
| Spruce Biosciences, Inc. | -1.24 USD | -87776.613% |
| Celldex Therapeutics, Inc. | -2.92 USD | -37217.466% |
| Cogent Biosciences, Inc. | -2.42 USD | -44927.686% |
| MacroGenics, Inc. | -0.15 USD | -726346.667% |
| RenovoRx, Inc. | -0.99 USD | -109967.677% |
| Adicet Bio, Inc. | -3.31 USD | -32820.544% |
| Prime Medicine, Inc. | -2.18 USD | -49884.862% |
| Aditxt, Inc. | -4326.64 USD | 74.815% |
| Adagene Inc. | -0.44 USD | -247552.273% |
| Estrella Immunopharma, Inc. | -0.21 USD | -518790.476% |
| Quantum-Si incorporated | -0.68 USD | -160145.588% |
| Maravai LifeSciences Holdings, Inc. | -0.90 USD | -120974.444% |
| Acurx Pharmaceuticals, Inc. | -1.15 USD | -94653.913% |
| Voyager Therapeutics, Inc. | 3.08 USD | 35478.896% |
| SciSparc Ltd. | -14.43 USD | -7451.421% |
| Vericel Corporation | -0.07 USD | -1628704.185% |
| Revelation Biosciences, Inc. | -0.53 USD | -205498.113% |
| Minerva Neurosciences, Inc. | -4.61 USD | -23537.093% |
| Generation Bio Co. | -1.96 USD | -55495.408% |
| Astria Therapeutics, Inc. | -2.42 USD | -44927.686% |
| Black Diamond Therapeutics, Inc. | -1.88 USD | -57861.17% |
| Arcutis Biotherapeutics, Inc. | -3.78 USD | -28727.249% |
| Invivyd, Inc. | -1.81 USD | -60102.762% |
| Relay Therapeutics, Inc. | -2.79 USD | -38956.272% |
| Quoin Pharmaceuticals, Ltd. | -9.64 USD | -11203.631% |
| Spero Therapeutics, Inc. | 0.43 USD | 253511.628% |
| Artelo Biosciences, Inc. | -3.49 USD | -31122.636% |
| 2seventy bio, Inc. | -4.42 USD | -24553.167% |
| ADMA Biologics, Inc. | -0.13 USD | -838107.692% |
| Clene Inc. | -9.43 USD | -11455.355% |
| Capricor Therapeutics, Inc. | -0.83 USD | -131185.542% |
| Boundless Bio, Inc. Common Stock | -2.22 USD | -48984.234% |
| GeoVax Labs, Inc. | -10.22 USD | -10562.133% |
| Recursion Pharmaceuticals, Inc. | -1.58 USD | -68866.456% |
| Citius Pharmaceuticals, Inc. | -0.22 USD | -495204.545% |
| Contineum Therapeutics, Inc. Class A Common Stock | 1.36 USD | 80222.794% |
| Relmada Therapeutics, Inc. | -3.28 USD | -33121.646% |
| Finch Therapeutics Group, Inc. | -46.59 USD | -2238.85% |
| ALX Oncology Holdings Inc. | -3.74 USD | -29035.561% |
| Vir Biotechnology, Inc. | -4.59 USD | -23640.087% |
| Evaxion Biotech A/S | -8.11 USD | -13336.128% |
| Ocular Therapeutix, Inc. | -1.09 USD | -99869.725% |
| Verve Therapeutics, Inc. | -3.12 USD | -34825.321% |
| Trevena, Inc. | -54.51 USD | -1899.028% |
| Surrozen, Inc. | -21.33 USD | -5008.626% |
| Tyra Biosciences, Inc. | -1.62 USD | -67163.58% |
| Cingulate Inc. | -311.99 USD | -249.264% |
| Galmed Pharmaceuticals Ltd. | -30.05 USD | -3526.19% |
| Unity Biotechnology, Inc. | -2.70 USD | -40258.148% |
| Tenax Therapeutics, Inc. | -31.09 USD | -3404.889% |
| Terns Pharmaceuticals, Inc. | -1.27 USD | -85700.787% |
| ACADIA Pharmaceuticals Inc. | -0.37 USD | -294405.405% |
| Connect Biopharma Holdings Limited | -1.08 USD | -100795.37% |
| Clearmind Medicine Inc. | -59.18 USD | -1741.281% |
| Kronos Bio, Inc. | -1.95 USD | -55780.513% |
| Bolt Biotherapeutics, Inc. | -1.83 USD | -59444.809% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -279302.564% |
| Viking Therapeutics, Inc. | -0.91 USD | -119643.956% |
| Statera Biopharma, Inc. | -4.97 USD | -21824.95% |
| ImmunityBio, Inc. | -1.15 USD | -94653.913% |
| Korro Bio, Inc. | -53.08 USD | -1952.882% |
| Kineta, Inc. | -1.28 USD | -85030.469% |
| BioVie Inc. | -7.30 USD | -14826.986% |
| Codexis, Inc. | -1.12 USD | -97191.964% |
| Celularity Inc. | -11.02 USD | -9788.113% |
| Crinetics Pharmaceuticals, Inc. | -3.69 USD | -29430.352% |
| Celcuity Inc. | -2.69 USD | -40408.178% |
| Virax Biolabs Group Limited | -3.36 USD | -32330.655% |
| Cibus, Inc. | -25.95 USD | -4099.114% |
| Eledon Pharmaceuticals, Inc. | -0.00 USD | -68104275.0% |
| eFFECTOR Therapeutics, Inc. | -16.37 USD | -6556.506% |
| IN8bio, Inc. | -1.00 USD | -108867.0% |
| Kodiak Sciences Inc. | -4.97 USD | -21824.95% |
| Annexon, Inc. | -1.77 USD | -61463.277% |
| Adverum Biotechnologies, Inc. | -11.62 USD | -9277.539% |
| Assembly Biosciences, Inc. | -13.38 USD | -8044.021% |
| Avalo Therapeutics, Inc. | -113.58 USD | -859.385% |
| Ionis Pharmaceuticals, Inc. | -2.56 USD | -42465.234% |
| Eyenovia, Inc. | -0.66 USD | -165001.515% |
| Puma Biotechnology, Inc. | 0.46 USD | 236984.783% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -1205287.168% |
| Xilio Therapeutics, Inc. | -2.78 USD | -39096.763% |
| Arcellx, Inc. | -1.47 USD | -74027.211% |
| Cardiff Oncology, Inc. | -0.93 USD | -117068.817% |
| Enanta Pharmaceuticals, Inc. | -6.38 USD | -16979.467% |
| Regulus Therapeutics Inc. | -1.58 USD | -68866.456% |
| Moolec Science SA | -1.50 USD | -72544.667% |
| Acumen Pharmaceuticals, Inc. | -1.08 USD | -100795.37% |
| Geron Corporation | -0.32 USD | -340421.875% |
| LAVA Therapeutics N.V. | -1.57 USD | -69305.732% |
| Royalty Pharma plc | 3.41 USD | 32055.132% |
| Atea Pharmaceuticals, Inc. | -1.63 USD | -66750.92% |
| Greenwich LifeSciences, Inc. | -0.69 USD | -157823.188% |
| TFF Pharmaceuticals, Inc. | -11.85 USD | -9095.527% |
| Mersana Therapeutics, Inc. | -1.48 USD | -73526.351% |
| Humacyte, Inc. | -1.07 USD | -101738.318% |
| Structure Therapeutics Inc. | -2.44 USD | -44558.607% |
| 89bio, Inc. | -2.00 USD | -54383.5% |
| PMV Pharmaceuticals, Inc. | -1.44 USD | -75571.528% |
| Avenue Therapeutics, Inc. | -73.60 USD | -1380.53% |
| Genelux Corporation | -1.16 USD | -93837.069% |
| Trevi Therapeutics, Inc. | -0.29 USD | -375648.276% |
| Lexicon Pharmaceuticals, Inc. | -0.80 USD | -136108.75% |
| Notable Labs, Ltd. | -5.03 USD | -21563.419% |
| Liquidia Corporation | -1.21 USD | -89955.372% |
| Mustang Bio, Inc. | -6.00 USD | -18061.167% |
| Immunovant, Inc. | -1.88 USD | -57861.17% |
| Quantum-Si incorporated | -0.68 USD | -160145.588% |
| Arbutus Biopharma Corporation | -0.44 USD | -247552.273% |
| DiaMedica Therapeutics Inc. | -0.60 USD | -181511.667% |
| Vera Therapeutics, Inc. | -2.25 USD | -48329.778% |
| Acasti Pharma Inc. | -1.35 USD | -80616.296% |
| MiNK Therapeutics, Inc. | -0.65 USD | -167541.538% |
| Pasithea Therapeutics Corp. | -12.65 USD | -8513.992% |
| Xenon Pharmaceuticals Inc. | -2.73 USD | -39814.652% |
| Elevai Labs, Inc. Common Stock | -0.40 USD | -272317.5% |
| NeuroBo Pharmaceuticals, Inc. | -2.46 USD | -44195.528% |
| Tempest Therapeutics, Inc. | -1.91 USD | -56950.785% |
| Soleno Therapeutics, Inc. | -2.36 USD | -46072.458% |
| PepGen Inc. | -3.30 USD | -32920.303% |
| Moleculin Biotech, Inc. | -15.07 USD | -7130.723% |
| United Therapeutics Corporation | 21.04 USD | 5279.04% |
| Nuvectis Pharma, Inc. | -1.43 USD | -76100.699% |
| Solid Biosciences Inc. | -4.83 USD | -22460.455% |
| BriaCell Therapeutics Corp. | -0.29 USD | -375648.276% |
| Immuneering Corporation | -1.88 USD | -57861.17% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -40865.038% |
| Silo Pharma, Inc. | -1.20 USD | -90705.833% |
| Belite Bio, Inc | -1.19 USD | -91468.908% |
| XOMA Corporation | -4.04 USD | -26872.03% |
| ARS Pharmaceuticals, Inc. | -0.57 USD | -191070.175% |
| Bionomics Limited | -1.02 USD | -106730.392% |
| Apogee Therapeutics, Inc. | -0.00 USD | -32049017.647% |
| Alpha Tau Medical Ltd. | -0.42 USD | -259345.238% |
| uniQure N.V. | -6.47 USD | -16741.886% |
| Cassava Sciences, Inc. | -2.32 USD | -46868.534% |
| Estrella Immunopharma, Inc. | -0.21 USD | -518790.476% |
| Poseida Therapeutics, Inc. | -1.37 USD | -79437.956% |
| Forte Biosciences, Inc. | -24.92 USD | -4272.673% |
| Anebulo Pharmaceuticals, Inc. | -0.32 USD | -340421.875% |
| Enlivex Therapeutics Ltd. | -1.56 USD | -69750.641% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -1205287.168% |
| SeaStar Medical Holding Corporation | -30.29 USD | -3497.458% |
| FibroBiologics, Inc. Common Stock | -0.59 USD | -184589.831% |
| Altimmune, Inc. | -1.66 USD | -65542.771% |
| Amicus Therapeutics, Inc. | -0.51 USD | -213560.784% |
| Alpha Tau Medical Ltd. | -0.42 USD | -259345.238% |
| Compugen Ltd. | -0.21 USD | -518790.476% |
| Peak Bio, Inc. | - USD | Infinity% |
| Zevra Therapeutics, Inc. | -1.30 USD | -83720.769% |
| Benitec Biopharma Inc. | -5.36 USD | -20229.664% |
| Spyre Therapeutics, Inc. | -49.12 USD | -2118.384% |
| NKGen Biotech, Inc. Common Stock | -5.38 USD | -20154.089% |
| Zura Bio Limited | -2.09 USD | -52037.321% |
| PolyPid Ltd. | -16.99 USD | -6313.596% |
| Aileron Therapeutics, Inc. | -3.42 USD | -31761.696% |
| NKGen Biotech, Inc. Warrants | -5.38 USD | -20154.089% |
| Instil Bio, Inc. | -24.00 USD | -4440.292% |
| argenx SE | -5.16 USD | -21017.636% |
| Immunome, Inc. | -5.38 USD | -20154.089% |
| Compass Therapeutics, Inc. | -0.33 USD | -330103.03% |
| Verona Pharma plc | -0.54 USD | -201690.741% |
| enGene Holdings Inc. Warrants | -4.51 USD | -24061.197% |
| Shattuck Labs, Inc. | -2.05 USD | -53054.634% |
| CervoMed Inc. | -0.82 USD | -132786.585% |
| LENZ Therapeutics, Inc. | -15.30 USD | -7022.026% |
| Plus Therapeutics, Inc. | -4.24 USD | -25599.764% |
| Dianthus Therapeutics, Inc. | -8.45 USD | -12795.503% |
| Moolec Science SA | -1.50 USD | -72544.667% |
| Enveric Biosciences, Inc. | -8.09 USD | -13369.345% |
| Inovio Pharmaceuticals, Inc. | -6.09 USD | -17792.775% |
| AnaptysBio, Inc. | -6.08 USD | -17822.204% |
| Design Therapeutics, Inc. | -1.19 USD | -91468.908% |
| Leap Therapeutics, Inc. | -3.98 USD | -27278.643% |
| NeurAxis, Inc. | -4.03 USD | -26938.958% |
| Seelos Therapeutics, Inc. | -7.73 USD | -13996.636% |
| Lumos Pharma, Inc. | -4.18 USD | -25968.66% |
| Achilles Therapeutics plc | -1.74 USD | -62524.713% |
| enGene Holdings Inc. Common Stock | -4.51 USD | -24061.197% |
| 180 Life Sciences Corp. | -52.60 USD | -1971.616% |
| Opiant Pharmaceuticals, Inc. | 0.68 USD | 160345.588% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -279302.564% |
| Nutriband Inc. | -0.69 USD | -157823.188% |
| ORIC Pharmaceuticals, Inc. | -1.96 USD | -55495.408% |
| CG Oncology, Inc. Common stock | -15.65 USD | -6862.748% |
| Fractyl Health, Inc. Common Stock | -1.98 USD | -54933.838% |
| Rani Therapeutics Holdings, Inc. | -1.33 USD | -81830.075% |
| MoonLake Immunotherapeutics | -0.73 USD | -149169.863% |
| Palisade Bio, Inc. | -27.01 USD | -3934.321% |
| Tourmaline Bio, Inc. | -8.87 USD | -12184.893% |
| Beam Therapeutics Inc. | -1.72 USD | -63252.907% |
| Neurogene Inc. | -2.83 USD | -38404.24% |
| Mirum Pharmaceuticals, Inc. | -4.00 USD | -27141.75% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -2.38 USD | -45684.454% |
| Sesen Bio, Inc. | -1.99 USD | -54657.286% |
| Enliven Therapeutics, Inc. | -2.01 USD | -54112.438% |
| Kiora Pharmaceuticals, Inc. | -24.25 USD | -4393.485% |
| Iovance Biotherapeutics, Inc. | -1.89 USD | -57554.497% |
| Taysha Gene Therapies, Inc. | -0.96 USD | -113407.292% |
| Athira Pharma, Inc. | -3.10 USD | -35050.645% |
| Vaccinex, Inc. | -43.68 USD | -2394.666% |
| HCW Biologics Inc. | -0.70 USD | -155567.143% |
| XOMA Corporation | -4.04 USD | -26872.03% |
| Nektar Therapeutics | -1.45 USD | -75049.655% |
| Arvinas, Inc. | -6.62 USD | -16360.272% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -272417400.0% |
| Merus N.V. | -3.00 USD | -36222.333% |
| Omega Therapeutics, Inc. | -1.80 USD | -60437.222% |
| Quince Therapeutics, Inc. | -0.84 USD | -129622.619% |
| Rezolute, Inc. | -1.33 USD | -81830.075% |
| Clene Inc. | -9.43 USD | -11455.355% |
| Indaptus Therapeutics, Inc. | -1.84 USD | -59121.196% |
| BeyondSpring Inc. | -0.54 USD | -201690.741% |
| Synlogic, Inc. | -8.81 USD | -12268.558% |
| Allarity Therapeutics, Inc. | -0.01 USD | -10579220.388% |
| Phio Pharmaceuticals Corp. | -46.87 USD | -2224.877% |
| Peak Bio, Inc. | - USD | Infinity% |
| Werewolf Therapeutics, Inc. | -1.05 USD | -103678.095% |
| Krystal Biotech, Inc. | 0.40 USD | 272517.5% |
| Karyopharm Therapeutics Inc. | -1.25 USD | -87073.6% |
| SpringWorks Therapeutics, Inc. | -5.15 USD | -21058.641% |
| Lipella Pharmaceuticals Inc. | -0.77 USD | -141415.584% |
| MannKind Corporation | -0.04 USD | -2437640.492% |
| Ikena Oncology, Inc. | -1.63 USD | -66750.92% |
| Cyclerion Therapeutics, Inc. | -8.99 USD | -12020.912% |
| Gyre Therapeutics, Inc. | -1.41 USD | -77181.56% |
| Gossamer Bio, Inc. | -1.18 USD | -92244.915% |
| CohBar, Inc. | -4.13 USD | -26284.262% |
| Cognition Therapeutics, Inc. | -0.86 USD | -126605.814% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -27278.643% |
| Legend Biotech Corporation | -2.94 USD | -36963.605% |
| Mural Oncology plc | -12.43 USD | -8666.452% |
| Biora Therapeutics, Inc. | -7.87 USD | -13745.87% |
| PaxMedica, Inc. Common Stock | -11.00 USD | -9806.091% |
| Disc Medicine, Inc. | -3.43 USD | -31668.805% |
| Champions Oncology, Inc. | -0.54 USD | -201690.741% |
| REGENXBIO Inc. | -6.02 USD | -18000.831% |
| Ensysce Biosciences, Inc. | -4.69 USD | -23133.902% |
| Anavex Life Sciences Corp. | -0.60 USD | -181511.667% |
| Cellectar Biosciences, Inc. | -3.11 USD | -34937.621% |
| Edgewise Therapeutics, Inc. | -1.57 USD | -69305.732% |
| Vaxart, Inc. | -0.57 USD | -191070.175% |
| PharmaCyte Biotech, Inc. | -1.80 USD | -60437.222% |
| Aldeyra Therapeutics, Inc. | -0.64 USD | -170160.938% |
| Cellectis S.A. | -1.77 USD | -61463.277% |
| Longeveron Inc. | -10.22 USD | -10562.133% |
| Repare Therapeutics Inc. | -2.23 USD | -48764.126% |
| Sarepta Therapeutics, Inc. | -5.80 USD | -18687.414% |
| Inozyme Pharma, Inc. | -1.37 USD | -79437.956% |
| Revolution Medicines, Inc. | -3.86 USD | -28129.793% |
| Nymox Pharmaceutical Corporation | -0.07 USD | -1482444.218% |
| Third Harmonic Bio, Inc. | -0.78 USD | -139601.282% |
| ArriVent BioPharma, Inc. Common Stock | -2.17 USD | -50115.207% |
| AN2 Therapeutics, Inc. | -2.74 USD | -39668.978% |
| Anixa Biosciences, Inc. | -0.32 USD | -340421.875% |
| Vertex Pharmaceuticals Incorporated | 14.05 USD | 7855.658% |
| Denali Therapeutics Inc. | -1.06 USD | -102699.057% |
| Revelation Biosciences, Inc. | -0.53 USD | -205498.113% |
| Veru Inc. | -1.10 USD | -98960.909% |
| Corvus Pharmaceuticals, Inc. | -0.56 USD | -194483.929% |
| Cingulate Inc. | -311.99 USD | -249.264% |
| Passage Bio, Inc. | -1.86 USD | -58484.409% |
| Context Therapeutics Inc. | -1.50 USD | -72544.667% |
| Exicure, Inc. | -2.11 USD | -51543.128% |
| Day One Biopharmaceuticals, Inc. | -2.37 USD | -45877.637% |
| Oramed Pharmaceuticals Inc. | -0.97 USD | -112237.113% |
| Scinai Immunotherapeutics Ltd. | -16.62 USD | -6456.378% |
| Rhythm Pharmaceuticals, Inc. | -3.20 USD | -33952.188% |
| Nuvalent, Inc. | -2.17 USD | -50115.207% |
| ABVC BioPharma, Inc. | -2.43 USD | -44742.387% |
| Carisma Therapeutics, Inc. | -2.59 USD | -41972.201% |
| Unicycive Therapeutics, Inc. | -1.28 USD | -85030.469% |
| OmniAb, Inc. | -0.51 USD | -213560.784% |
| Anew Medical, Inc. | 0.14 USD | 778435.714% |
| Fennec Pharmaceuticals Inc. | -0.60 USD | -181511.667% |
| Lipocine Inc. | -3.14 USD | -34602.866% |
| Lexeo Therapeutics, Inc. Common Stock | -2.49 USD | -43661.847% |
| Nautilus Biotechnology, Inc. | -0.51 USD | -213560.784% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -14162.696% |
| G1 Therapeutics, Inc. | -0.93 USD | -117068.817% |
| Bellerophon Therapeutics, Inc. | -2.08 USD | -52287.981% |
| Sage Therapeutics, Inc. | -9.05 USD | -11940.552% |
| Ocugen, Inc. | -0.26 USD | -419003.846% |
| Mind Medicine (MindMed) Inc. | -2.44 USD | -44558.607% |
| Q32 Bio Inc. | -35.16 USD | -2999.175% |
| Brainstorm Cell Therapeutics Inc. | -0.40 USD | -272317.5% |
| Alumis Inc. Common Stock | -2.99 USD | -36343.813% |
| Equillium, Inc. | -0.38 USD | -286655.263% |
| Kyverna Therapeutics, Inc. | -0.00 USD | -1089669900.0% |
| Coya Therapeutics, Inc. | -0.79 USD | -137832.911% |
| CNS Pharmaceuticals, Inc. | -251.35 USD | -333.527% |
| Galera Therapeutics, Inc. | -1.33 USD | -81830.075% |
| Evelo Biosciences, Inc. | -26.28 USD | -4046.385% |
| Comera Life Sciences Holdings, Inc. | -1.76 USD | -61813.068% |
| Dominari Holdings Inc. | -4.38 USD | -24778.311% |
| Edesa Biotech, Inc. | -2.93 USD | -37090.102% |
| vTv Therapeutics Inc. | -9.71 USD | -11122.142% |
| Bio-Techne Corporation | 1.07 USD | 101938.318% |
| Agios Pharmaceuticals, Inc. | -6.33 USD | -17114.376% |
| Harmony Biosciences Holdings, Inc. | 2.17 USD | 50315.207% |
| Prelude Therapeutics Incorporated | -2.02 USD | -53844.059% |
| Candel Therapeutics, Inc. | -1.31 USD | -83080.916% |
| iTeos Therapeutics, Inc. | -3.15 USD | -34492.698% |
| Nkarta, Inc. | -2.40 USD | -45302.917% |
| BioCardia, Inc. | -8.19 USD | -13204.884% |
| Iterum Therapeutics plc | -2.96 USD | -36713.176% |